You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1024 CLN-978, a novel CD19/CD3/HSA T cell engager with extended serum half-life, is effective against lymphoma cells expressing very low levels of CD19

Alerts

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune Cell Types and Biology
1024 CLN-978, a novel CD19/CD3/HSA T cell engager with extended serum half-life, is effective against lymphoma cells expressing very low levels of CD19
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address